Eagle Pharmaceuticals Inc sell Piper Sandler
Start price
09.08.23
/
50%
€17.90
Target price
09.08.24
-
Performance (%)
-71.51%
Price
03.07.24
€5.10
Summary
This prediction is currently active. The SELL prediction by Piper_Sandler for Eagle Pharmaceuticals Inc is performing very well with a performance of -71.51%. This prediction currently runs until 09.08.24. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Eagle Pharmaceuticals Inc | 21.429% | 21.429% |
iShares Core DAX® | 1.175% | -0.931% |
iShares Nasdaq 100 | 1.232% | 9.715% |
iShares Nikkei 225® | 1.563% | 3.040% |
iShares S&P 500 | 0.034% | 5.962% |
Comments by Piper_Sandler for this prediction
In the thread Eagle Pharmaceuticals Inc diskutieren
Eagle Pharmaceuticals, Inc. (NASDAQ: EGRX) was downgraded by analysts at Piper Sandler from a "neutral" rating to an "underweight" rating.
Ratings data for EGRX provided by MarketBeat